Table 4.
Changes in the oxLDL (U/l) in serum at the baseline and after the intervention (mean±SD and meand±SEd)
| oxLDL (U/l) | |||||
|---|---|---|---|---|---|
| C group | E group | B group | COM group | P group | |
| Before | 86.93± 26.30 | 94.52 ± 38.40 | 79.73 ±2.07 | 85.97±23.07 | 84.90± 14.661 |
| After | 70.99± 16.46 | 71.95 ± 17.897 | 65.99±16.72 | 69.57± 14.99 | 83.20± 15.68 |
| Meand ±SEd (within groups) | -15.93± 5.33 | -22.56± 5.89 | -13.73± 2.9 | -16.40± 3.49 | -1.70± 1.31 |
| Changing Percent | -18.32 | -23.86 | -17.31 | -19.07 | -2.0 |
| P value | 0.005* | 0.000* | 0.000* | *0.000 | 0.213 |
* P value <0.05 is significantly different
Test non-parametric, Wilcoxon, was used to compare pre-post tests